Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 22, 2019

Study Completion Date

January 31, 2026

Conditions
Pancreatic Neoplasms
Interventions
DRUG

Ascorbate

Intravenous infusion of high-dose ascorbate

DRUG

Gemcitabine

Intravenous chemotherapeutic

RADIATION

Radiation therapy

Trial Locations (1)

52242

The Holden Comprehensive Cancer Center, Iowa City

All Listed Sponsors
collaborator

Holden Comprehensive Cancer Center

OTHER

collaborator

Gateway for Cancer Research

OTHER

lead

Joseph J. Cullen

OTHER